Next-generation sequencing: The solution for high-resolution, unambiguous human leukocyte antigen typing

Human Immunology

Volumn 71, Issue 10, 2010, Pages 1033-1042

  Lind, C ^a   Ferriola, D ^a   Mackiewicz, K ^a   Heron, S ^a   Rogers, M ^a   Slavich, L ^a   Walker, R ^a   Hsiao, T ^a   McLaughlin, L ^a   D'Arcy, M ^a   Gai, X ^a   Goodridge, D ^b   Sayer, D ^b   Monos, D ^a,c  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b Conexio Genomics ^*  (Australia)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Ambiguities; DNA sequencing; High resolution HLA typing; HLA polymorphism

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN;

ARTICLE; GENE AMPLIFICATION; HLA TYPING; HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

DIAGNOSTIC ERRORS; DNA PRIMERS; FEASIBILITY STUDIES; HISTOCOMPATIBILITY TESTING; HUMANS; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA;

EID: 77956618378     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.06.016     Document Type: Article

References (38)

1. Robinson J., Waller M.J., Fail S.C., McWilliam H., Lopez R., Parham P., Marsh S.G. The IMGT/HLA database. Nucleic Acids Res 2009, 37:D1013-D1017.
2. Adams S.D., Barracchini K.C., Chen D., Robbins F., Wang L., Larsen P., et al. Ambiguous allele combinations in HLA Class I and Class II sequence-based typing: when precise nucleotide sequencing leads to imprecise allele identification. J Transl Med 2004, 2:30.
3. NMDP Policy for Confirmatory Typing. J Doc 2005, National Marrow Donor Program, A00261 ver 1.0.
4. NMDP Policy for Confirmatory Typing. J Doc 2009, National Marrow Donor Program, A00261 ver 2.
5. Cano P., Klitz W., Mack S.J., Maiers M., Marsh S.G., Noreen H., et al. Common and well-documented HLA alleles: report of the Ad-hoc committee of the American Society for Histocompatiblity and Immunogenetics. Hum Immunol 2007, 68:392-417.
6. Shendure J., Ji H. Next-generation DNA sequencing. Nat Biotechnol 2008, 26:1135-1145.
7. Metzker M.L. Sequencing technologies-the next generation. Nat Rev Genet 2010, 11:31-46.
8. GS FLX Shotgun DNA Library Preparation Method Manual-December 2007.
9. GS FLX emPCR Method Manual-December 2007.
10. GS FLX Sequencing Method Manual-December 2007.
11. Margulies M., Egholm M., Altman W.E., Attiya S., Bader J.S., Bemben L.A., et al. Genome sequencing in microfabricated high-density picolitre reactors. Nature 2005, 437:376-380.
12. Gabriel C., Danzer M., Hackl C., Kopal G., Hufnagl P., Hofer K., et al. Rapid high-throughput human leukocyte antigen typing by massively parallel pyrosequencing for high-resolution allele identification. Hum Immunol 2009, 70:960-964.
13. Bravo H.C., Irizarry R.A. Model-based. quality assessment and base-calling for second-generation sequencing data. Biometrics 2009.
14. Hedges D., Burges D., Powell E., Almonte C., Huang J., Young S., et al. Exome sequencing of a multigenerational human pedigree. PLoS ONE 2009, 4:e8232.
15. Harismendy O., Ng P.C., Strausberg R.L., Wang X., Stockwell T.B., Beeson K.Y., et al. Evaluation of next generation sequencing platforms for population targeted sequencing studies. Genome Biol 2009, 10:R32.
16. Harismendy O., Frazer K. Method for improving sequence coverage uniformity of targeted genomic intervals amplified by LR-PCR using Illumina GA sequencing-by-synthesis technology. BioTechniques 2009, 46:229-231.
17. Bentley G., Higuchi R., Hoglund B., Goodridge D., Sayer D., Trachtenberg E.A., Erlich H.A. High-resolution, high-throughput HLA genotyping by next-generation sequencing. Tissue Antigens 2009, 74:393-403.
18. Elsner H.A., Bernard G., Eiz-Vesper B., de Matteis M., Bernard A., Blasczyk R. Non-expression of HLA-A*2901102 N is caused by a nucleotide exchange in the mRNA splicing site at the beginning of intron. 4. Tissue Antigens 2002, 59:139-141.
19. Curran M.D., Williams F., Little A.M., Rima B.K., Madrigal J.A., Middleton D. Aberrant splicing of intron 1 creates a novel null HLA-B*1501 allele. Tissue Antigens 1999, 53:244-252.
20. Sutton V.R., Kienzle B.K., Knowles R.W. An altered splice site is found in the DRB4 gene that is not expressed in HLA-DR7, Dw11 individuals. Immunogenetics 1989, 29:317-322.
21. Lee S.J., Klein J., Haagenson M., Baxter-Lowe L.A., Confer D.L., Eapen M., et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007, 110:4576-4583.
22. Loiseau P., Busson M., Balere M.L., Dormoy A., Bignon J.D., Gagne K., et al. HLA Association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival. Biol Blood Marrow Transplant 2007, 13:965-974.
23. Flomenberg N., Baxter-Lowe L.A., Confer D., Fernandez-Vina M., Filipovich A., Horowitz M., et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood 2004, 104:1923-1930.
24. Baxter-Lowe L.A., Maiers M., Spellman S.R., Haagenson M.D., Wang T., Fernandez-Vina M., et al. HLA-A disparities illustrate challenges for ranking the impact of HLA mismatches on bone marrow transplant outcomes in the United States. Biol Blood Marrow Transplant 2009, 15:971-981.
25. Xiao Y., Lazaro A.M., Masaberg C., Haagenson M., Vierra-Green C., Spellman S., et al. Evaluating the potential impact of mismatches outside the antigen recognition site in unrelated hematopoietic stem cell transplantation: HLA-DRB1*1454 and DRB1*140101. Tissue Antigens 2009, 73:595-598.
26. Almeciga I., Wang Z.C., Zúñiga J., Fernandez-Viña M., Clavijo O., Araujo H., et al. Allorecognition of an HLA-A*01 aberrant allele by an HLA identical family member carrying the HLA-A*0101 allele. J Immunol 2006, 177:8643-8649.
27. Eckels D.D. Solid phase testing in the HLA Laboratory: implications for organ allocation. Int J Immunogenet 2008, 35:265-274.
28. Claas F.H. HLA antibody testing: a tool to facilitate not to prevent organ transplantation. Int J Immunogenet 2008, 35:275-277.
29. Gebel H.M., Moussa O., Eckels D.D., Bray R.A. Donor-reactive HLA antibodies in renal allograft recipients: considerations, complications, and conundrums. Hum Immunol 2009, 70:610-617.
30. Lomago J., Jelenik L., Zern D., Howe J., Martell J., Zeevi A., Duquesnoy R.J. How did a patient who types for HLA-B*4403 develop antibodies that react with HLA-B*4402?. Hum Immunol 2010, 71:176-178.
31. Alper C.A., Larsen C.E., Dubey D.P., Awdeh Z.L., Fici D.A., Yunis E.J. The haplotype structure of the human major histocompatibility complex. Hum Immunol 2006, 67:73-84.
32. Cullen M., Perfetto S.P., Klitz W., Nelson G., Carrington M. High-resolution patterns of meiotic recombination across the human major histocompatibility complex. Am J Hum Genet 2002, 71:759-776.
33. Sanchez-Mazas A., Djoulah S., Busson M., de Le M., Gouville I., Poirier J.C., et al. A linkage disequilibrium map of the MHC region based on the analysis of 14 loci haplotypes in 50 French families. Eur J Hum Genet 2000, 8:33-41.
34. Beck S., Trowsdale J. The human major histocompatability complex: lessons from the DNA sequence. Annu Rev Genomics Hum Genet 2000, 1:117-137.
35. Arora M., Weisdorf D.J., Spellman S.R., Haagenson M.D., Klein J.P., Hurley C.K., et al. HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia. J Clin Oncol 2009, 27:1644-1652.
36. Beatty P.G., Clift R.A., Mickelson E.M., Nisperos B.B., Flournoy N., Martin P.J., et al. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 1985, 313:765-767.
37. Szydlo R., Goldman J.M., Klein J.P., Gale R.P., Ash R.C., Bach F.H., et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol 1997, 15:1767-1777.
38. Weisdorf D.J., Anasetti C., Antin J.H., Kernan N.A., Kollman C., Snyder D., et al. Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation. Blood 2002, 99:1971-1977.